We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
CG
1
Column Group
California
$324M
RCP
2
Rho Capital Partners
New York
$79.2M
RG
3
Redmile Group
California
$52.7M -$6.33M -287,330 -10%
BlackRock
4
BlackRock
New York
$51.4M +$3.2M +145,477 +6%
SG
5
StepStone Group
California
$33.1M +$34.6M +1,573,357 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$32.8M +$3.77M +171,051 +12%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$30.3M +$12.7M +578,794 +67%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$27.5M +$28.8M +1,307,937 New
PIM
9
Ponoi II Management
California
$27.3M
PM
10
Ponoi Management
California
$27.3M
BI
11
BVF Inc
California
$20.1M
EC
12
Euclidean Capital
New York
$17.5M -$14.6M -661,075 -44%
Citadel Advisors
13
Citadel Advisors
Florida
$15.9M +$1.11M +50,576 +7%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$13.5M +$1.5M +68,077 +12%
JP Morgan Chase
15
JP Morgan Chase
New York
$13.2M +$314K +14,245 +2%
State Street
16
State Street
Massachusetts
$13.1M +$584K +26,545 +4%
CS
17
Candriam SCA
Luxembourg
$11.9M
BC
18
Boxer Capital
California
$10.5M
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$9.63M +$4.52M +205,123 +81%
Axa
20
Axa
France
$8.52M +$2.49M +112,926 +39%
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$8.09M -$1.08M -49,142 -11%
JRP
22
Jasper Ridge Partners
California
$6.52M
Northern Trust
23
Northern Trust
Illinois
$6.29M +$44.5K +2,020 +0.7%
BBA
24
Baker Bros. Advisors
New York
$6.13M
HWAM
25
Hennion & Walsh Asset Management
New Jersey
$5.82M -$208K -9,468 -3%